EUVIMEDEUVIMED entdecken
Multizentrische Studie

Arsenic‐induced neurotoxicity in patients with acute promyelocytic leukaemia

Zoe Loh iD, Michael Ashby, Ellie Van Veldhuizen, Wenlong Li, Ashlyn Chee iD, Winpa Aung, Yelena Lavrukhina, George Mason, Tenille Pelly, Rithin Nedumannil iD, Serena Kosciejew, Mridula Mokoonlall und 11 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19297 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Zoe Loh und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Haematology, Austin Health, Heidelberg, Victoria, Australia. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, Arsenic Trioxide, Neurotoxicity Syndromes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arsenic trioxide is an essential component of therapy for acute promyelocytic leukaemia (APL) and is currently dosed on actual body weight with no upper limit. Arsenic‐induced neurotoxicity is a well‐recognised complication; however, there is uncertainty about its relationship to arsenic dose and obesity. We conducted a large multicentre retrospective study of 487 patients with APL treated with arsenic‐based therapy across 23 sites in Australia from 2008 to 2023. The primary outcome was incidence of neurotoxicity, and secondary outcomes included relationship of neurotoxicity to obesity and cumulative arsenic dose. Any‐grade neurotoxicity occurred in 113 (23%) patients, predominantly peripheral neuropathy (91%). Most events were grade 1–2 severity (85%), with grade 3 events in 12% and grade 4–5 in 3%. The incidence of neurotoxicity increased with BMI (non‐obese: 16%, obesity class I: 25%, obesity class II–III: 41%; p < 0.001). On univariable analysis, obesity class I (OR 1.81, p = 0.036), obesity class II–III (OR 3.93, p < 0.001), weight >100 kg (OR 2.72, p < 0.001), daily arsenic trioxide dose >15 mg (OR 5.05, p < 0.001) and cumulative induction dose >500 mg (OR 3.95, p < 0.001) were all significantly associated with neurotoxicity. Obesity class II–III and induction dose >500 mg remained significant on multivariable analysis. Our study highlights the strong association between BMI, arsenic trioxide dose and neurotoxicity. Pre‐emptive dose reductions should be considered for obese patients receiving high doses of arsenic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Promyelocytic, AcuteArsenic TrioxideNeurotoxicity SyndromesHumansMaleFemaleMiddle AgedAdultRetrospective StudiesAgedObesityAustraliaArsenicYoung AdultAdolescentAged, 80 and over

Stichwörter der Autor:innen

acute promyelocytic leukaemialeukaemia therapypharmacology

Substanzen

Arsenic TrioxideArsenic

Autor:innen und Institutionen

  • Department of Clinical Haematology, Austin Health, Heidelberg, Victoria, Australia.
  • Department of Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia.
  • Department of Clinical Haematology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
  • Department of Clinical Haematology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Department of Clinical Haematology, Concord Hospital, Concord, New South Wales, Australia.
  • Department of Clinical Haematology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.

ORCID-Profile: Zoe Loh, Ashlyn Chee, Rithin Nedumannil

Zitieren

APA

Loh, Z., Ashby, M., Van Veldhuizen, E., Li, W., Chee, A., Aung, W., Lavrukhina, Y., Mason, G., Pelly, T., Nedumannil, R., Kosciejew, S., Mokoonlall, M., Lim, J., Calov, G., Butler, L., Hillebrand, P., Beekman, A., Rathnasekara, G. K., Raj, S., …, & Grigg, A. (2024). Arsenic‐induced neurotoxicity in patients with acute promyelocytic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.19297

Vancouver

Loh Z, Ashby M, Van Veldhuizen E, Li W, Chee A, Aung W, et al. Arsenic‐induced neurotoxicity in patients with acute promyelocytic leukaemia. British Journal of Haematology. 2024. doi:10.1111/bjh.19297

BibTeX
@article{Loh2024,
  author = {Loh, Zoe and Ashby, Michael and Van Veldhuizen, Ellie and Li, Wenlong and Chee, Ashlyn and Aung, Winpa and Lavrukhina, Yelena and Mason, George and Pelly, Tenille and Nedumannil, Rithin and Kosciejew, Serena and Mokoonlall, Mridula and Lim, Jonathan and Calov, Georgina and Butler, Llewyn and Hillebrand, Paulina and Beekman, Ashley and Rathnasekara, Greasha Kalani and Raj, Sonia and Zhang, Cathey and Yao, Yao and Iland, Harry and Grigg, Andrew},
  title = {Arsenic‐induced neurotoxicity in patients with acute promyelocytic leukaemia},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19297}
}
Kostenlos starten →